FinalDose • Active • 5 employees • LondonFinalDose is building the first programmable drug - a single smart drug molecule that you can insert any diseased genetic code and it can search and destroy cells upon DNA recognition. Unlocking 80% of undruggable targets today. Starting with all cancers.
artificial-intelligence
gene-therapy
therapeutics
genetic-engineering